Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.
[ad_1] The drug maker Biogen said on Wednesday that a panel of drug reviewers in the European Union had indicated that its new Alzheimer’s drug was unlikely to be approved
Twitter expands its subscription service to news articles.
[ad_1] Twitter said on Tuesday that it would give users access to ad-free articles from The Washington Post, Reuters, BuzzFeed and other publications through its subscription service, called Twitter Blue.The
Germany’s $9 billion digital bank N26 to withdraw from the U.S.
[ad_1] N26 co-founder and CEO Valentin Stalf speaks on stage during TechCrunch's Disrupt Berlin event at Treptow Arena on November 30, 2018 in Berlin, Germany.Noam Galai | Getty Images for
CCNA Certification Training Course Online
Take your networking skills to the next level with our comprehensive CCNA Certification Training Course Online. Gain essential knowledge and practical skills through interactive online classes. Prepare for the CCNA
Now in Your Inbox: Political Misinformation
[ad_1] A few weeks ago, Representative Dan Crenshaw, a Texas Republican, falsely claimed that the centerpiece of President Biden’s domestic agenda, a $1.75 trillion bill to battle climate change and
